Daniel Pizana
Adult Health · San Antonio, TXNPI 1164980827
Payments from drug & device makers
Across 91 payments — averaging $53.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$961
- Daiichi Sankyo Inc.$560
- Incyte Corporation$462
- Gilead$398
- Stemline Therapeutics Inc.$263
- Caris MPI, Inc.$258
- plus $2K from 16 others
What the payments were for
- Food & beverage$4,43192%
- Education$4028%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $961 |
| Daiichi Sankyo Inc. | 12 | $560 |
| Incyte Corporation | 4 | $462 |
| Gilead | 8 | $398 |
| Stemline Therapeutics Inc. | 3 | $263 |
| Caris MPI, Inc. | 12 | $258 |
| Johnson & Johnson | 2 | $249 |
| Seagen Inc. | 2 | $230 |
| Exelixis Inc. | 2 | $225 |
| Lilly USA, LLC | 6 | $190 |
| E.r. Squibb & Sons, L.L.C. | 2 | $178 |
| Pfizer | 6 | $154 |
| AbbVie | 1 | $125 |
| ADC Therapeutics America, Inc. | 1 | $123 |
| Rigel Pharmaceuticals, Inc. | 1 | $106 |
| Bristol Myers Squibb | 1 | $87 |
| Eisai Inc. | 4 | $72 |
| Astellas Pharma US Inc | 1 | $70 |
| Amgen | 3 | $52 |
| Genentech USA, Inc. | 1 | $28 |
| Merck | 1 | $27 |
| Tempus AI, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,833 in reported general payments places this provider in the 85th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 31 | $6,751 |
| Anastrozole | 210 | $3,216 |
| Letrozole | 27 | $724 |
| Tamoxifen Citrate | 19 | $616 |
| Alendronate Sodium | 67 | $421 |
| Ondansetron Hcl | 17 | $397 |
| Dicyclomine Hcl | 11 | $125 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 14 | $93 |
| Potassium Chloride | 14 | $74 |
| Montelukast Sodium | 12 | $34 |
| Prednisone | 19 | $29 |
Paid to pharmacies, not to this prescriber.
Other adult health in San Antonio
- Mary SalazarSan Antonio$68K
- Lafitte HolmesSan Antonio$13K
- Misty SheddAllen$863K
- Melodie YoungDallas$700K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Eric KlappholzDallas$44K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.